OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
MRVM55

Maven Renovar VCT PLC

UK Investment TrustsVerified

Maven Renovar VCT PLC operates with a fully diluted share count of 140,340,885 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible instruments. The company's liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents, suggesting a lack of transparency in its short-term financial flexibility. Profitability and return metrics are not available for Maven Renovar VCT PLC, as no valuation snapshot data is provided. This absence of data prevents a direct comparison to industry_config preferred metrics or cohort medians, limiting the ability to assess its performance relative to peers. The company's revenue concentration and geographic exposure are not disclosed in the available data, making it difficult to evaluate the risk associated with its segments or regions. Without segment-level revenue breakdowns, it is unclear whether the company is overexposed to any particular market or asset class. Growth trajectory is also indeterminate, as no outlook data is available to quantify revenue or earnings changes for the current or next fiscal year. Historical revenue data is not provided, further limiting the ability to model future performance. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The low dilution risk is supported by the equality of basic and diluted shares, but the absence of balance-sheet inputs and going-concern language introduces uncertainty about the company's financial health. Recent events, including filings or transcripts, are not disclosed in the available data, leaving the company's strategic direction and operational developments opaque.

30-day price · MRVM+3.47 (+6.9%)
Low$49.10High$54.50Close$53.50As of15 May, 00:00 UTC
Profile
CompanyMaven Renovar VCT PLC
TickerMRVM.L
SectorFinancials
BusinessCollective Investments
Industry groupCollective Investments
IndustryUK Investment Trusts
AI analysis

Business. Maven Renovar VCT PLC is a UK-listed investment trust that primarily invests in renewable energy and infrastructure projects, generating returns through dividends and capital appreciation.

Classification. Maven Renovar VCT PLC is classified under the Financials sector, specifically within the Collective Investments business sector and the UK Investment Trusts industry, with a classification confidence of 0.92.

Maven Renovar VCT PLC operates with a fully diluted share count of 140,340,885 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible instruments. The company's liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents, suggesting a lack of transparency in its short-term financial flexibility. Profitability and return metrics are not available for Maven Renovar VCT PLC, as no valuation snapshot data is provided. This absence of data prevents a direct comparison to industry_config preferred metrics or cohort medians, limiting the ability to assess its performance relative to peers. The company's revenue concentration and geographic exposure are not disclosed in the available data, making it difficult to evaluate the risk associated with its segments or regions. Without segment-level revenue breakdowns, it is unclear whether the company is overexposed to any particular market or asset class. Growth trajectory is also indeterminate, as no outlook data is available to quantify revenue or earnings changes for the current or next fiscal year. Historical revenue data is not provided, further limiting the ability to model future performance. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The low dilution risk is supported by the equality of basic and diluted shares, but the absence of balance-sheet inputs and going-concern language introduces uncertainty about the company's financial health. Recent events, including filings or transcripts, are not disclosed in the available data, leaving the company's strategic direction and operational developments opaque.
Key takeaways
  • Maven Renovar VCT PLC is a UK-listed investment trust focused on renewable energy and infrastructure.
  • The company has no difference between basic and diluted shares, indicating no dilution risk from options or convertibles.
  • Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language.
  • Profitability and return metrics are not available, limiting the ability to compare with industry benchmarks.
  • Revenue concentration and geographic exposure are not disclosed, making it difficult to assess risk diversification.
  • Growth trajectory and recent strategic developments are indeterminate due to missing outlook and event data.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyGBP
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$70.3M$66.7M$66.7M
FY-3-$17.4M-$22.4M-$22.4M
FY-2-$53.9M-$58.2M-$58.2M
FY-1-$41.6M-$44.8M-$44.8M
FY0$21.0k-$2.8M-$2.9M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$240.4M$238.3M
FY-3$248.5M$247.1M
FY-2$202.3M$201.3M
FY-1$144.0M$143.1M$30.5M
FY0$112.2M$111.5M$13.2M
PeriodOCFCapExFCFSBC
FY-4-$2.7M
FY-3-$4.3M
FY-2-$3.2M
FY-1-$1.3M
FY0-$742.0k
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: UK Investment Trusts · cohort 1 companies
MetricMRVMActivity
Op margin86.0% medp25 53.6% · p75 95.9%
Net margin84.2% medp25 47.0% · p75 95.4%
Gross margin90.3% medp25 73.4% · p75 97.4%
CapEx / revenue-0.1% medp25 -0.1% · p75 -0.1%
Debt / equity3.8% medp25 0.0% · p75 9.5%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 10:07 UTC#f84f5e49
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 15:48 UTCJob: 550a71e3